Get the Stockscreener App
130.06
0.77%
-1.01
After Hours:
130.06
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $130.06, with a volume of 540.78K.
It is down -0.77% in the last 24 hours and down -8.68% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$131.07
Open:
$130.48
24h Volume:
540.78K
Relative Volume:
0.74
Market Cap:
$6.99B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-14.11
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-2.42%
1M Performance:
-8.68%
6M Performance:
-22.68%
1Y Performance:
-21.32%
1-Day Range:
$129.77
$131.95
1-Week Range:
$129.77
$133.79
52-Week Range:
$129.77
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
130.06 | 7.04B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
125.29 | 218.72B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.35 | 142.33B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.47 | 135.42B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.06 | 123.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.25 | 50.02B | 5.88B | 1.34B | 799.60M | 2.3489 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corporation stock hits 52-week low at 131.47 USD By Investing.com - Investing.com Canada
Masimo Corporation stock hits 52-week low at 131.47 USD - Investing.com
Masimo Corporation $MASI Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech - Kalkine Media
Apple Seeks To Overturn $634M Masimo Patent Verdict - Law360
Apple Asks Judge to Toss Masimo’s $634 Million Watch-Alerts Win - Bloomberg Law News
Masimo Corporation $MASI Shares Sold by Perpetual Ltd - MarketBeat
Why Masimo Corporation stock is trending among retail tradersLayoff News & Weekly Market Pulse Alerts - Улправда
Energy Moves: Why Masimo Corporation (3M4) stock is a strong analyst pickJuly 2025 Volume & Consistent Profit Trade Alerts - Улправда
Masimo Corporation $MASI Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Corient Private Wealth LLC Sells 17,624 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Masimo stock hits 52-week low at 133.66 USD By Investing.com - Investing.com Nigeria
Masimo stock hits 52-week low at 133.66 USD - Investing.com
Masimo Corporation $MASI Shares Sold by Holocene Advisors LP - MarketBeat
Masimo Corporation $MASI Shares Sold by Liontrust Investment Partners LLP - MarketBeat
Masimo Corporation $MASI Shares Purchased by Bellevue Group AG - MarketBeat
Masimo Corporation $MASI Stock Holdings Lifted by 4D Advisors LLC - MarketBeat
United States Clinical Alarm Management Market to Grow at 32.2% - openPR.com
Russell Investments Group Ltd. Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Bank of Nova Scotia Lowers Position in Masimo Corporation $MASI - MarketBeat
Apple Tells Fed. Circ. ITC Move Boosts Watch Case Appeal - Law360
45,648 Shares in Masimo Corporation $MASI Acquired by Natixis - MarketBeat
Norges Bank Acquires New Stake in Masimo Corporation $MASI - MarketBeat
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI) - Yahoo Finance
Masimo Corporation $MASI Shares Sold by Franklin Resources Inc. - MarketBeat
Walleye Capital LLC Decreases Stake in Masimo Corporation $MASI - MarketBeat
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Masimo (MASI) Stock Is Up, What You Need To Know - Finviz
Masimo (NASDAQ:MASI) Price Target Raised to $200.00 - MarketBeat
JPMorgan Chase & Co. Cuts Stake in Masimo Corporation $MASI - MarketBeat
Alpha Wave Global LP Invests $17.17 Million in Masimo Corporation $MASI - MarketBeat
Will Masimo Corporation (3M4) stock remain on Wall Street radarMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser
Masimo stock price target raised to $200 from $198 at BTIG on growth outlook By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Masimo stock with $180 price target - Investing.com Canada
Needham reiterates Hold rating on Masimo stock after investor day By Investing.com - Investing.com Australia
What's Going On With Masimo Stock Thursday?Masimo (NASDAQ:MASI) - Benzinga
Masimo Pitches 2028 Plan With 30% Operating Margins - Sahm
Stifel reiterates Buy rating on Masimo stock with $180 price target By Investing.com - Investing.com South Africa
Masimo (NASDAQ:MASI) Releases FY 2028 Earnings Guidance - MarketBeat
BTIG Raises Price Target for Masimo (MASI) to $200 | MASI Stock News - GuruFocus
Masimo stock price target raised to $200 from $198 at BTIG on growth outlook - Investing.com
Masimo Gives Company Update at 2025 Investor Day - Orange County Business Journal
Masimo Corp Hosts 2025 Investor Day and Reveals Strategic Growth Plans - TradingView — Track All Markets
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth - Yahoo Finance
Transcript : Masimo CorporationAnalyst/Investor Day - marketscreener.com
Masimo (NASDAQ: MASI) targets ~30% margin, $8.00 EPS in 2028 plan for durable growth - Stock Titan
Is Masimo Corporation stock attractive for ETFsEarnings Miss & Free Reliable Trade Execution Plans - Newser
Will Masimo Corporation (3M4) stock test record highs in 2025Oil Prices & Reliable Trade Execution Plans - Newser
How Masimo Corporation (3M4) stock reacts to weak economyEarnings Recap Report & Weekly Top Gainers Alerts - Newser
What downside risks could hit Masimo Corporation (3M4) stockWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):